Our Partners
To develop and implement its activities, SEARN has closely collaborated and relied on a network of development partners, and especially through a dedicated Coalition of Interested Parties.
The below information is intended to acknowledge and express our gratitude for this critical support, as well as to facilitate direct contact between SEARN members and these partners.
CEPI, the Coalition for Epidemic Preparedness Innovations
CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats.
CEPI is honoured to be working with SEARN and is providing the following support to the associated working groups and action points:
- Provision of Subject Matter Expert Support
- Input and review of policies, procedures and other relevant documentation
- Attendance and input to relevant meetings, workshops and working groups
- Input into Training Activities
- Generation and presentation of training associated with Regulatory and Quality best practices
- Inputting into and reviewing curriculum, training and workshop design
- Facilitate Collaborations
- Twinning opportunities with experienced Regulators and Manufacturers to review “best practices”, expand knowledge and develop a support network
- Provision of funds
- Funding can be provided to support specific activities which are aligned with CEPIs vision, mission and objectives.
SEARN members may contact the CEPI representative linked to the SEARN Working Group and associated Action Points, or through the secretariat the Global Regulatory Affairs Asia Pacific lead or the Head GxP Quality and Compliance.
Centre of Regulatory Excellence, Duke-NUS Medical School
The Centre of Regulatory Excellence (CoRE) at the Duke-National University of Singapore (Duke-NUS) Medical School was established with support from Singapore’s Economic Development Board, Health Sciences Authority and Ministry of Health as the first centre in Asia dedicated to addressing the capacity development and policy innovation needs of national health product and health systems regulators, the biomedical industry, pharmaceutical and medical device companies, and biomedical researchers. Formally inaugurated in November 2014, CoRE was established at Duke-NUS in Singapore to support the strengthening of health regulatory systems in the Asia-Pacific region, with a special focus on South-East Asia. CoRE provides a neutral platform for stakeholder interaction, learning and discussion in the academic setting of Duke-NUS Medical School. Aligned with the Duke-NUS vision of “Transforming Medicine, Improving Lives”, CoRE focuses on being a neutral scientific regulatory entity, “Enabling regulatory excellence, Improving lives”. In this regard, CoRE is working closely with the Singapore Ministry of Health, Health Sciences Authority, healthtech and health technology assessment agencies as well as international economies to explore new paradigms of converging health products and services regulation to respond to new biomedical and therapeutic developments.
Please contact CoRE at this email: gmsbx103@nus.edu.sg
International Society of Pharmacovigilance
The International Society of Pharmacovigilance (ISoP) is an international non-profit scientific organisation, which aims to foster Pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, in all countries.
Contact: Angela Caro-Rojas (president@isoponline.org and administration@isoponline.org)
Swissmedic, Swiss Agency for Therapeutic Products
Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products.
Contact: networking@swissmedic.ch
Therapeutic Goods Administration (TGA)
The Therapeutic Goods Administration (TGA) is responsible for the regulation of medical products, including medicines, vaccines, medical devices, and diagnostic tests, in Australia.
The TGA delivers the Indo-Pacific Regulatory Strengthening Program (RSP) with support from the Australian Government under the Partnerships for a Healthy Region initiative. The RSP incorporates 22 countries in Southeast Asia and the Pacific, and aims to improve access to quality-assured medical products that are safe and effective through strengthening regulatory functions and systems. The Program involves the delivery of in-country and virtual capacity building activities, that are designed in response to identified needs and align with the WHO’s Global Benchmarking Tool framework.
Contact: rsp@health.gov.au
United States Pharmacopeia (USP)
USP is an independent scientific organization that collaborates with the world's top experts in health and science to develop quality resources and standards for medicines, dietary supplements, and food ingredients. Through our resources, standards, advocacy, and education, USP helps increase the availability of quality medicines, supplements, and foods for billions of people worldwide.